NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.230
+0.010 (0.82%)
Dec 5, 2025, 4:00 PM EST - Market closed
NanoViricides Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Selling, General & Admin | 3.61 | 4.04 | 3.08 | 2.55 | 2.33 | 2.63 | |
| Research & Development | 4.61 | 5.55 | 5.44 | 6.39 | 5.78 | 6.11 | |
| Operating Expenses | 8.22 | 9.59 | 8.52 | 8.94 | 8.11 | 8.74 | |
| Operating Income | -8.22 | -9.59 | -8.52 | -8.94 | -8.11 | -8.74 | |
| Interest Expense | -0 | -0 | -0.05 | -0 | -0.01 | -0.09 | |
| Interest & Investment Income | 0.1 | 0.12 | 0.27 | 0.36 | 0.01 | 0.01 | |
| EBT Excluding Unusual Items | -8.13 | -9.47 | -8.29 | -8.59 | -8.11 | -8.82 | |
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -0 | |
| Pretax Income | -8.13 | -9.47 | -8.29 | -8.59 | -8.11 | -8.82 | |
| Net Income | -8.13 | -9.47 | -8.29 | -8.59 | -8.11 | -8.82 | |
| Net Income to Common | -8.13 | -9.47 | -8.29 | -8.59 | -8.11 | -8.82 | |
| Shares Outstanding (Basic) | 16 | 15 | 12 | 12 | 12 | 11 | |
| Shares Outstanding (Diluted) | 16 | 15 | 12 | 12 | 12 | 11 | |
| Shares Change (YoY) | 29.00% | 27.34% | 2.11% | 0.79% | 5.81% | 94.08% | |
| EPS (Basic) | -0.51 | -0.63 | -0.70 | -0.74 | -0.70 | -0.81 | |
| EPS (Diluted) | -0.51 | -0.63 | -0.70 | -0.74 | -0.70 | -0.81 | |
| Free Cash Flow | -7.57 | -8.54 | -6.47 | -5.82 | -6.22 | -8.45 | |
| Free Cash Flow Per Share | -0.47 | -0.56 | -0.55 | -0.50 | -0.54 | -0.78 | |
| EBITDA | -7.54 | -8.85 | -7.76 | -8.2 | -7.39 | -8.04 | |
| D&A For EBITDA | 0.68 | 0.74 | 0.76 | 0.75 | 0.72 | 0.7 | |
| EBIT | -8.22 | -9.59 | -8.52 | -8.94 | -8.11 | -8.74 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.